{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T22:23:12Z","timestamp":1773008592799,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T00:00:00Z","timestamp":1237939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1479-5876-7-22","type":"journal-article","created":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T19:25:11Z","timestamp":1238009111000},"source":"Crossref","is-referenced-by-count":32,"title":["Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model"],"prefix":"10.1186","volume":"7","author":[{"given":"Hui-ling","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-qiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Worschech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-fen","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-yi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F","family":"Stroncek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ena","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco M","family":"Marincola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,3,25]]},"reference":[{"key":"333_CR1","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1126\/science.275.5297.218","volume":"275","author":"M Jang","year":"1997","unstructured":"Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997, 275: 218-220. 10.1126\/science.275.5297.218.","journal-title":"Science"},{"key":"333_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1006\/abbi.2000.1973","volume":"381","author":"MJ Burkitt","year":"2000","unstructured":"Burkitt MJ, Duncan J: Effects of trans-resveratrol on copper-dependent hydroxyl-radical formation and DNA damage: evidence for hydroxyl-radical scavenging and a novel, glutathione-sparing mechanism of action. Arch Biochem Biophys. 2000, 381: 253-263. 10.1006\/abbi.2000.1973.","journal-title":"Arch Biochem Biophys"},{"key":"333_CR3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/mnfr.200500022","volume":"49","author":"CA de la Lastra","year":"2005","unstructured":"de la Lastra CA, Villegas I: Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res. 2005, 49: 405-430. 10.1002\/mnfr.200500022.","journal-title":"Mol Nutr Food Res"},{"key":"333_CR4","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1086\/429694","volume":"191","author":"AT Palamara","year":"2005","unstructured":"Palamara AT, Nencioni L, Aquilano K, De CG, Hernandez L, Cozzolino F: Inhibition of influenza A virus replication by resveratrol. J Infect Dis. 2005, 191: 1719-1729. 10.1086\/429694.","journal-title":"J Infect Dis"},{"key":"333_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1124\/mi.6.1.7","volume":"6","author":"DK Das","year":"2006","unstructured":"Das DK, Maulik N: Resveratrol in cardioprotection: a therapeutic promise of alternative medicine. Mol Interv. 2006, 6: 36-47. 10.1124\/mi.6.1.7.","journal-title":"Mol Interv"},{"key":"333_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2174\/157489007780832560","volume":"2","author":"S Das","year":"2007","unstructured":"Das S, Das DK: Resveratrol: a therapeutic promise for cardiovascular diseases. Recent Patents Cardiovasc Drug Discov. 2007, 2: 133-138. 10.2174\/157489007780832560.","journal-title":"Recent Patents Cardiovasc Drug Discov"},{"key":"333_CR7","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1093\/carcin\/bgg105","volume":"24","author":"T Ito","year":"2003","unstructured":"Ito T, Akao Y, Yi H, Ohguchi K, Matsumoto K, Tanaka T: Antitumor effect of resveratrol oligomers against human cancer cell lines and the molecular mechanism of apoptosis induced by vaticanol C. Carcinogenesis. 2003, 24: 1489-1497. 10.1093\/carcin\/bgg105.","journal-title":"Carcinogenesis"},{"key":"333_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1158\/0008-5472.CAN-03-1656","volume":"64","author":"S Fulda","year":"2004","unstructured":"Fulda S, Debatin KM: Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res. 2004, 64: 337-346. 10.1158\/0008-5472.CAN-03-1656.","journal-title":"Cancer Res"},{"key":"333_CR9","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1158\/1535-7163.MCT-05-0198","volume":"4","author":"Q Zhang","year":"2005","unstructured":"Zhang Q, Tang X, Lu QY, Zhang ZF, Brown J, Le AD: Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1alpha and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells. Mol Cancer Ther. 2005, 4: 1465-1474. 10.1158\/1535-7163.MCT-05-0198.","journal-title":"Mol Cancer Ther"},{"key":"333_CR10","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1016\/S0024-3205(00)00888-2","volume":"67","author":"WK Chan","year":"2000","unstructured":"Chan WK, Delucchi AB: Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4. Life Sci. 2000, 67: 3103-3112. 10.1016\/S0024-3205(00)00888-2.","journal-title":"Life Sci"},{"key":"333_CR11","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1158\/1078-0432.CCR-03-0105","volume":"10","author":"SH Tseng","year":"2004","unstructured":"Tseng SH, Lin SM, Chen JC, Su YH, Huang HY, Chen CK: Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin Cancer Res. 2004, 10: 2190-2202. 10.1158\/1078-0432.CCR-03-0105.","journal-title":"Clin Cancer Res"},{"key":"333_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ijc.20856","volume":"115","author":"E Pozo-Guisado","year":"2005","unstructured":"Pozo-Guisado E, Merino JM, Mulero-Navarro S, Lorenzo-Benayas MJ, Centeno F, varez-Barrientos A: Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB. Int J Cancer. 2005, 115: 74-84. 10.1002\/ijc.20856.","journal-title":"Int J Cancer"},{"key":"333_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1021\/np049702i","volume":"68","author":"LM Szewczuk","year":"2005","unstructured":"Szewczuk LM, Lee SH, Blair IA, Penning TM: Viniferin formation by COX-1: evidence for radical intermediates during co-oxidation of resveratrol. J Nat Prod. 2005, 68: 36-42. 10.1021\/np049702i.","journal-title":"J Nat Prod"},{"key":"333_CR14","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/carcin\/bgi165","volume":"26","author":"A Tyagi","year":"2005","unstructured":"Tyagi A, Singh RP, Agarwal C, Siriwardana S, Sclafani RA, Agarwal R: Resveratrol causes Cdc2-tyr15 phosphorylation via ATM\/ATR-Chk1\/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells. Carcinogenesis. 2005, 26: 1978-1987. 10.1093\/carcin\/bgi165.","journal-title":"Carcinogenesis"},{"key":"333_CR15","first-page":"7456","volume":"61","author":"KP Bhat","year":"2001","unstructured":"Bhat KP, Lantvit D, Christov K, Mehta RG, Moon RC, Pezzuto JM: Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models. Cancer Res. 2001, 61: 7456-7463.","journal-title":"Cancer Res"},{"key":"333_CR16","doi-asserted-by":"publisher","first-page":"7460","DOI":"10.1074\/jbc.M411565200","volume":"280","author":"CM Klinge","year":"2005","unstructured":"Klinge CM, Blankenship KA, Risinger KE, Bhatnagar S, Noisin EL, Sumanasekera WK: Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. J Biol Chem. 2005, 280: 7460-7468. 10.1074\/jbc.M411565200.","journal-title":"J Biol Chem"},{"key":"333_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1677\/ERC-06-0020","volume":"14","author":"P Galluzzo","year":"2007","unstructured":"Galluzzo P, Caiazza F, Moreno S, Marino M: Role of ERbeta palmitoylation in the inhibition of human colon cancer cell proliferation. Endocr Relat Cancer. 2007, 14: 153-167. 10.1677\/ERC-06-0020.","journal-title":"Endocr Relat Cancer"},{"key":"333_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/08982100600848819","volume":"16","author":"J Rejman","year":"2006","unstructured":"Rejman J, Conese M, Hoekstra D: Gene transfer by means of lipo- and polyplexes: role of clathrin and caveolae-mediated endocytosis. J Liposome Res. 2006, 16: 237-247. 10.1080\/08982100600848819.","journal-title":"J Liposome Res"},{"key":"333_CR19","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1042\/bst0290494","volume":"29","author":"B Razani","year":"2001","unstructured":"Razani B, Schlegel A, Liu J, Lisanti MP: Caveolin-1, a putative tumour suppressor gene. Biochem Soc Trans. 2001, 29: 494-499. 10.1042\/BST0290494.","journal-title":"Biochem Soc Trans"},{"key":"333_CR20","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/S0002-9440(10)64442-2","volume":"161","author":"CC Ho","year":"2002","unstructured":"Ho CC, Huang PH, Huang HY, Chen YH, Yang PC, Hsu SM: Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. Am J Pathol. 2002, 161: 1647-1656.","journal-title":"Am J Pathol"},{"key":"333_CR21","doi-asserted-by":"publisher","first-page":"41295","DOI":"10.1074\/jbc.R200020200","volume":"277","author":"P Liu","year":"2002","unstructured":"Liu P, Rudick M, Anderson RG: Multiple functions of caveolin-1. J Biol Chem. 2002, 277: 41295-41298. 10.1074\/jbc.R200020200.","journal-title":"J Biol Chem"},{"key":"333_CR22","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1161\/01.ATV.0000081743.35125.05","volume":"23","author":"TE Peterson","year":"2003","unstructured":"Peterson TE, Guicciardi ME, Gulati R, Kleppe LS, Mueske CS, Mookadam M: Caveolin-1 can regulate vascular smooth muscle cell fate by switching platelet-derived growth factor signaling from a proliferative to an apoptotic pathway. Arterioscler Thromb Vasc Biol. 2003, 23: 1521-1527. 10.1161\/01.ATV.0000081743.35125.05.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"333_CR23","doi-asserted-by":"publisher","first-page":"23176","DOI":"10.1074\/jbc.M402051200","volume":"279","author":"MS Duxbury","year":"2004","unstructured":"Duxbury MS, Ito H, Ashley SW, Whang EE: CEACAM6 cross-linking induces caveolin-1-dependent, Src-mediated focal adhesion kinase phosphorylation in BxPC3 pancreatic adenocarcinoma cells. J Biol Chem. 2004, 279: 23176-23182. 10.1074\/jbc.M402051200.","journal-title":"J Biol Chem"},{"key":"333_CR24","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.cardiores.2004.06.026","volume":"64","author":"A Graziani","year":"2004","unstructured":"Graziani A, Bricko V, Carmignani M, Graier WF, Groschner K: Cholesterol- and caveolin-rich membrane domains are essential for phospholipase A2-dependent EDHF formation. Cardiovasc Res. 2004, 64: 234-242. 10.1016\/j.cardiores.2004.06.026.","journal-title":"Cardiovasc Res"},{"key":"333_CR25","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1210\/en.141.10.3657","volume":"141","author":"JL Bowers","year":"2000","unstructured":"Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM: Resveratrol acts as a mixed agonist\/antagonist for estrogen receptors alpha and beta. Endocrinology. 2000, 141: 3657-3667. 10.1210\/en.141.10.3657.","journal-title":"Endocrinology"},{"key":"333_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/j.1745-7270.2007.00270.x","volume":"39","author":"H Yang","year":"2007","unstructured":"Yang H, He S, Quan Z, Peng W, Yan B, Liu J: Small interfering RNA-mediated caveolin-1 knockout on plasminogen activator inhibitor-1 expression in insulin-stimulated human vascular endothelial cells. Acta Biochim Biophys Sin (Shanghai). 2007, 39: 224-233. 10.1111\/j.1745-7270.2007.00270.x.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"333_CR27","first-page":"297","volume":"13","author":"YY Xu","year":"2006","unstructured":"Xu YY, Yang HL, Tu J: The construction, Identification and primary functional analysis of pcDNA3.1\/NT-GFP-Caveolin-1 and mutants plasmids. Chin J Atheroscler. 2006, 13: 297-300.","journal-title":"Chin J Atheroscler"},{"key":"333_CR28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.bbrc.2004.12.159","volume":"328","author":"HL Yang","year":"2005","unstructured":"Yang HL, Jiang HJ, Fang WY, Xu YY, Liao DF, He FC: High fidelity PCR with an off\/on switch mediated by proofreading polymerases combining with phosphorothioate-modified primer. Biochem Biophys Res Commun. 2005, 328: 265-272. 10.1016\/j.bbrc.2004.12.159.","journal-title":"Biochem Biophys Res Commun"},{"key":"333_CR29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00029330-200801020-00004","volume":"121","author":"HL Yang","year":"2008","unstructured":"Yang HL, Xu YY, DU LF, Liu CH, Zhao Q, Wei WJ: Chemokine SR-PSOX\/CXCL16 expression in peripheral blood of patients with acute coronary syndrome. Chin Med J (Engl). 2008, 121: 112-117.","journal-title":"Chin Med J (Engl)"},{"key":"333_CR30","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1745-7270.2007.00264.x","volume":"39","author":"Z Quan","year":"2007","unstructured":"Quan Z, Yang H, Yang Y, Yan B, Cao R, Wen G: Construction and functional analysis of a lentiviral expression vector containing a scavenger receptor (SR-PSOX) that binds uniquely phosphatidylserine and oxidized lipoprotein. Acta Biochim Biophys Sin (Shanghai). 2007, 39: 208-216. 10.1111\/j.1745-7270.2007.00264.x.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"333_CR31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/00000478-200403000-00008","volume":"28","author":"LM Yerian","year":"2004","unstructured":"Yerian LM, Anders RA, Tretiakova M, Hart J: Caveolin and thrombospondin expression during hepatocellular carcinogenesis. Am J Surg Pathol. 2004, 28: 357-364. 10.1097\/00000478-200403000-00008.","journal-title":"Am J Surg Pathol"},{"key":"333_CR32","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1242\/jcs.02894","volume":"119","author":"VA Torres","year":"2006","unstructured":"Torres VA, Tapia JC, Rodriguez DA, Parraga M, Lisboa P, Montoya M: Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin. J Cell Sci. 2006, 119: 1812-1823. 10.1242\/jcs.02894.","journal-title":"J Cell Sci"},{"key":"333_CR33","doi-asserted-by":"publisher","first-page":"6214","DOI":"10.1158\/0008-5472.CAN-04-0001","volume":"64","author":"RI Pakunlu","year":"2004","unstructured":"Pakunlu RI, Wang Y, Tsao W, Pozharov V, Cook TJ, Minko T: Enhancement of the efficacy of chemotherapy for lung cancer by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense: novel multicomponent delivery system. Cancer Res. 2004, 64: 6214-6224. 10.1158\/0008-5472.CAN-04-0001.","journal-title":"Cancer Res"},{"key":"333_CR34","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1158\/0008-5472.CAN-05-3256","volume":"66","author":"LA Hazlehurst","year":"2006","unstructured":"Hazlehurst LA, Argilagos RF, Emmons M, Boulware D, Beam CA, Sullivan DM: Cell adhesion to fibronectin (CAM-DR) influences acquired mitoxantrone resistance in U937 cells. Cancer Res. 2006, 66: 2338-2345. 10.1158\/0008-5472.CAN-05-3256.","journal-title":"Cancer Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-7-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1479-5876-7-22\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-7-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T05:24:17Z","timestamp":1548134657000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-7-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,25]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["333"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-7-22","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,25]]},"article-number":"22"}}